CFG vs COYA · P/E 15, rev $2.28B vs rev $7.9M
Citizens Financial Group, Inc. (CFG) versus Coya Therapeutics, Inc. Common Stock (COYA) — a side-by-side from cached financials, not a winner call.
Citizens Financial Group, Inc. (CFG) is a banks - regional company listed on US.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Latest reported CFG revenue for 2026-06-30 was $2.28B. Net income was $587.0M. Revenue was up 5.3% from 2026-03-31 to 2026-06-30. CFG currently screens at market cap $20.67B and trailing P/E 15.1.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
CFG currently screens at market cap $20.67B and trailing P/E 15.1. COYA currently screens at market cap $118.0M.
Not investment advice. Open the CFG and COYA stock pages for the full models.
Not investment advice.